NCT05081063View on ClinicalTrials.gov

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

199

Participants

Timeline

Start Date

March 5, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions

Hemorrhagic ShockAcute Blood Loss AnemiaTraumatic Brain Injury

Interventions

COMBINATION_PRODUCT

Routine labs

Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.

Trial Locations (1)

92354

Loma Linda University Health, Loma Linda

All Listed Sponsors

lead

Loma Linda University

OTHER